6-氨基己酸(EACA)是一种单氨基羧酸,在血学实验室中,用于防止血凝块的纤维蛋白溶解。到五十年代后期,EACA由于其毒性极少而被选用于治疗血友病病人的出血。虽然仅报告了少数EACA伴发的死亡——多数病人可能是死于EACA治疗后发生血栓形成——却使人们拒绝使用这个药物。EACA主要经由血浆素元激活质以及 6-Aminocaproic acid (EACA) is a monoaminocarboxylic acid that is used in hematology laboratories to prevent fibrinolysis of blood clots. By the late fifties, EACA was chosen for the treatment of bleeding in patients with hemophilia due to its minimal toxicity. Although only a few deaths associated with EACA have been reported, most of whom may have died of thrombosis following EACA treatment, they have been denied access to the drug. EACA mainly through the plasma elemental activator as well